Clinical Trials Results - National Cancer Institute

Skip to content

National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov


	Clinical Trials Search Results

	Quick Links


	Director's Corner Dictionary of Cancer Terms NCI Drug Dictionary Funding Opportunities NCI Publications Advisory Boards and Groups Science Serving People Español

Questions about cancer?


	1-800-4-CANCER

	LiveHelp® online chat

	NCI Highlights


	High Dose Chemotherapy Prolongs Survival for Leukemia Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E Past Highlights



Results: 1 -3 of 3 Show results per page	View Search Criteria \| Help With Results


Sort By:	Version:	Format:


1.		Phase II Chemotherapy with MTX/CF, Aminopterin or M-BACOD plus CTX or BCG Immunotherapy for Advanced non-Hodgkin's Lymphoma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III, Phase II				Treatment				Closed				25 to 65								DFCI-75116

Last Modified: 8/8/2008 First Published: 6/1/1999


2.		Phase II Study of Aminopterin in Patients With Refractory Leukemia

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Closed				Any age				Pharmaceutical / Industry				ILEX-AMT-002/1997 UTSMC-AMT-002/1997, UTSMC-FDR001458, NCI-V99-1534, NCT00003305

Last Modified: 7/1/2000 First Published: 5/1/1999


3.		Phase II Study of Aminopterin in Patients with Persistent, Recurrent, or Refractory Endometrial Carcinoma (Summary Last Modified 07/2000)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Closed				Not specified				Pharmaceutical / Industry				ILEX-AMT221-A1 ILEX-AMT221, NCI-V99-1531, NCT00003821

Select All on One Page

| | | | | | | |

A Service of the National Cancer Institute